STOCK TITAN

H.B. Fuller Announces Preliminary Fiscal Year 2024 Results

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Negative)
Tags

H.B. Fuller (NYSE: FUL) has released preliminary financial results for fiscal year 2024, revising its expectations downward. The company now projects net revenue of $3.57 billion, adjusted diluted EPS of $3.84, and adjusted EBITDA of $594 million, falling short of its previous EBITDA guidance of $610-620 million. Cash flow from operations is expected at approximately $300 million.

The fourth quarter performance was negatively impacted by weaker market conditions and delayed orders, particularly in consumer product goods, packaging, and durable goods distribution. Higher raw material costs, especially in Hygiene, Health and Consumable Adhesives, along with delayed customer order patterns shifting price increase realization into fiscal 2025, affected adjusted EBITDA. In response, the company is implementing new pricing actions, cost controls, and continuing restructuring initiatives to streamline manufacturing and SG&A.

H.B. Fuller (NYSE: FUL) ha pubblicato i risultati finanziari preliminari per l'anno fiscale 2024, rivedendo le sue aspettative al ribasso. L'azienda ora prevede ricavi netti di 3,57 miliardi di dollari, utili per azione diluiti rettificati di 3,84 dollari e EBITDA rettificato di 594 milioni di dollari, al di sotto della precedente indicazione dell'EBITDA di 610-620 milioni di dollari. Si prevede un flusso di cassa dalle operazioni di circa 300 milioni di dollari.

Le performance del quarto trimestre sono state negativamente influenzate dalle condizioni di mercato più deboli e dai ritardi negli ordini, in particolare nei beni di consumo, nell'imballaggio e nella distribuzione di beni durevoli. I costi più elevati delle materie prime, soprattutto nel settore Igiene, Salute e Collanti Monouso, insieme a schemi di ordini dei clienti ritardati che hanno spostato il realizzo dei aumenti di prezzo all'anno fiscale 2025, hanno influito sull'EBITDA rettificato. In risposta, l'azienda sta implementando nuove azioni di pricing, controlli sui costi e continuando le iniziative di ristrutturazione per ottimizzare la produzione e le spese generali e amministrative.

H.B. Fuller (NYSE: FUL) ha publicado resultados financieros preliminares para el año fiscal 2024, revisando sus expectativas a la baja. La compañía ahora proyecta ingresos netos de 3,57 mil millones de dólares, EPS diluido ajustado de 3,84 dólares y EBITDA ajustado de 594 millones de dólares, por debajo de su anterior orientación de EBITDA de 610-620 millones de dólares. Se espera que el flujo de efectivo de las operaciones sea de aproximadamente 300 millones de dólares.

El rendimiento del cuarto trimestre se vio afectado negativamente por condiciones de mercado más débiles y pedidos retrasados, especialmente en bienes de consumo, empaque y distribución de bienes duraderos. Los costos más altos de las materias primas, especialmente en Higiene, Salud y Adhesivos Consumibles, junto con los patrones de pedidos de clientes retrasados que han trasladado la realización de aumentos de precios al año fiscal 2025, afectaron el EBITDA ajustado. En respuesta, la compañía está implementando nuevas acciones de precios, controles de costos y continuando las iniciativas de reestructuración para optimizar la manufactura y los gastos generales y administrativos.

H.B. 풀러 (NYSE: FUL)는 2024 회계연도에 대한 예비 재무 결과를 발표하며 기대치를 하향 조정했습니다. 회사는 이제 넷 수익 35.7억 달러, 조정된 희석 주당순이익 3.84 달러, 조정된 EBITDA 5.94억 달러를 예상하며, 이전의 EBITDA 가이던스인 6.10-6.20억 달러에 미치지 못합니다. 운영을 통한 현금 흐름은 약 3억 달러로 예상됩니다.

4분기 실적은 약세 시장 조건과 지연된 주문으로 부정적인 영향을 받았으며, 특히 소비재, 포장재 및 내구재 유통에서 그러했습니다. 원자재 비용 상승, 특히 위생, 건강 및 소비성 접착제 분야에서의 높은 비용과 고객 주문 패턴의 지연이 가격 인상 실현을 2025 회계연도로 미루게 만들면서 조정된 EBITDA에 영향을 미쳤습니다. 이에 따라 회사는 새로운 가격 책정 조치를 시행하고 비용 통제를 강화하며 제조 및 SG&A를 간소화하기 위한 구조 조정 이니셔티브를 지속하고 있습니다.

H.B. Fuller (NYSE: FUL) a publié des résultats financiers préliminaires pour l'exercice 2024, révisant à la baisse ses attentes. L'entreprise prévoit désormais un chiffre d'affaires net de 3,57 milliards de dollars, un BPA dilué ajusté de 3,84 dollars et un EBITDA ajusté de 594 millions de dollars, ce qui est en deçà de ses précédentes prévisions d'EBITDA de 610-620 millions de dollars. Le flux de trésorerie opérationnel est estimé à environ 300 millions de dollars.

Les performances du quatrième trimestre ont été négativement affectées par des conditions de marché plus faibles et des commandes retardées, en particulier dans les biens de consommation, l'emballage et la distribution de biens durables. La hausse des coûts des matières premières, surtout dans les domaines de l'hygiène, de la santé et des adhésifs consommables, ainsi que les schémas de commande des clients retardés, ont déplacé la réalisation des hausses de prix vers l'exercice 2025, ce qui a affecté l'EBITDA ajusté. En réponse, l'entreprise met en œuvre de nouvelles actions tarifaires, des contrôles des coûts et continue ses initiatives de restructuration pour rationaliser la production et les frais généraux.

H.B. Fuller (NYSE: FUL) hat vorläufige Finanzzahlen für das Geschäftsjahr 2024 veröffentlicht und seine Erwartungen nach unten korrigiert. Das Unternehmen rechnet nun mit einem Nettoumsatz von 3,57 Milliarden Dollar, einem bereinigten verwässerten EPS von 3,84 Dollar und einem bereinigten EBITDA von 594 Millionen Dollar, was unter der vorherigen EBITDA-Prognose von 610-620 Millionen Dollar liegt. Der Cashflow aus dem operativen Geschäft wird auf etwa 300 Millionen Dollar geschätzt.

Die Leistung im vierten Quartal wurde negativ von schwächeren Marktbedingungen und verzögerten Bestellungen beeinflusst, insbesondere im Bereich Konsumgüter, Verpackung und Distribution von langlebigen Gütern. Höhere Rohstoffkosten, insbesondere in den Bereichen Hygiene, Gesundheit und Verbraucherklebstoffe, sowie verzögerte Bestellmuster von Kunden, die die Preiserhöhung in das Geschäftsjahr 2025 verschoben haben, haben das bereinigte EBITDA betroffen. In Reaktion darauf implementiert das Unternehmen neue Preisanpassungen, Kostenkontrollen und setzt die Umstrukturierungsinitiativen fort, um die Produktion und die Verwaltungskosten zu optimieren.

Positive
  • Implementing cost control measures and restructuring initiatives
  • Planned pricing actions to address margin pressures
Negative
  • Adjusted EBITDA guidance reduced to $594M from $610-620M range
  • Weaker than expected Q4 market conditions affecting revenue
  • Higher raw material costs impacting margins
  • Delayed customer orders pushing price increase benefits to 2025
  • Negative volume inflection in multiple market segments

Insights

H.B. Fuller's preliminary FY2024 results reveal concerning operational headwinds. The $3.57 billion revenue projection alongside adjusted EBITDA of $594 million falls significantly short of the previous $610-620 million guidance. The $3.84 adjusted EPS and $300 million operating cash flow indicate deteriorating market conditions. Two critical red flags emerge: 1) Volume deceleration across multiple segments in Q4, particularly in consumer goods and packaging markets, suggesting broader demand weakness, 2) Raw material cost pressures in the HHC Adhesives segment coupled with delayed price increase implementation, creating margin compression. Management's reactive measures through new pricing actions and cost controls, while necessary, may face execution challenges in a weakening market environment. The timing of price increase realization shifting to FY2025 could prolong margin recovery.

The preliminary results highlight a broader industry-wide challenge in the specialty chemicals sector. The volume deceleration in consumer product goods and packaging markets serves as a leading indicator of potential economic softening. Customer order delays and distribution weakness in durable goods suggest inventory destocking continues to impact the value chain. The timing mismatch between raw material cost increases and price realization creates a negative operating leverage effect that could persist into early 2025. This pattern often precedes a cyclical downturn in the chemicals sector. The company's manufacturing footprint optimization and SG&A restructuring initiatives, while strategic, may take several quarters to yield meaningful cost benefits, leaving near-term profitability vulnerable to market conditions.

The operational disruptions evident in H.B. Fuller's results reflect systemic supply chain challenges. The delay in customer orders and price increase implementation points to inventory management issues throughout the value chain. Raw material cost inflation in the HHC Adhesives segment suggests persistent supply constraints in key inputs. The 2.6% miss in adjusted EBITDA versus the lower end of previous guidance ($594M vs. $610M) indicates the magnitude of these supply chain inefficiencies. The company's focus on manufacturing footprint streamlining is important but requires careful execution to avoid further disrupting supply chain stability. These challenges could impact working capital efficiency and cash flow generation in the near term.

ST. PAUL, Minn.--(BUSINESS WIRE)-- H.B. Fuller Company (NYSE: FUL) announced today unaudited preliminary financial results for fiscal year 2024 and scheduled the company’s fourth quarter investor conference call. These preliminary results are estimates and remain subject to completion of the company’s fiscal year financial audit.

The company now expects fiscal year 2024 net revenue to be approximately $3.57 billion, adjusted diluted earnings per share to be approximately $3.84 and adjusted EBITDA to be approximately $594 million compared to previous guidance of adjusted EBITDA between $610 million and $620 million as communicated on September 25, 2024. Additionally, the company now expects cash flow from operations for the year to be approximately $300 million.

Fourth quarter net revenue and earnings were adversely impacted by weaker than expected conditions and delayed orders, particularly in consumer product goods and packaging related end markets as well as durable goods distribution. In addition, delayed customer order patterns shifted price increase realization into fiscal 2025 while higher raw material costs, primarily in Hygiene, Health and Consumable (HHC) Adhesives, negatively impacted adjusted EBITDA.

“Late in the fourth quarter there was a negative inflection point on volume whereby a number of market segments exhibited topline deceleration versus the previous quarter, and this adversely impacted our operating results and led to a disappointing shortfall relative to our expectations,” said Celeste Mastin, President and Chief Executive Officer. “In response to this weaker market environment, we are focusing on the controllable variables and putting in place new pricing actions and cost controls. This is in addition to our ongoing restructuring initiatives to streamline our manufacturing footprint and overall SG&A profile.”

The Company plans to report its financial results for the three-month and twelve-month fiscal periods ended November 30, 2024, in a press release issued after the market close on January 15, 2025. The Company will hold an investor conference call on January 16, 2025, at 9:30 a.m. CT (10:30 a.m. ET) to discuss its financial results.

Interested parties may listen to the conference call on a live webcast. The webcast, along with a supplemental presentation, may be accessed from the company’s website at https://investors.hbfuller.com. Participants must register prior to accessing the webcast using this link and should do so at least 10 minutes prior to the start of the call to install and test any necessary software and audio connections. Participants can pre-register for the webcast at any time using the link above. The webcast will be archived on the company’s website.

A telephone replay of the conference call will be available from 12:30 p.m. CT on January 16, 2025, to 10:59 p.m. CT on January 23, 2025. To access the telephone replay dial 1-800-770-2030 (toll free) or 1-609-800-9909 and enter the Conference ID: 6370505.

Regulation G

The information presented in this release regarding consolidated adjusted net income, adjusted diluted earnings per share, and adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) does not conform to U.S. generally accepted accounting principles (U.S. GAAP) and should not be construed as an alternative to the reported results determined in accordance with U.S. GAAP. Management has included this non-GAAP information to assist in understanding the operating performance of the Company as well as the comparability of results to the results of other companies. The non-GAAP information provided may not be consistent with the methodologies used by other companies. All non-GAAP information is reconciled with reported U.S. GAAP results in this release.

About H.B. Fuller

As the largest pureplay adhesives company in the world, H.B. Fuller’s (NYSE: FUL) innovative, functional coatings, adhesives and sealants enhance the quality, safety and performance of products people use every day. Founded in 1887, with 2023 revenue of $3.5 billion, our mission to Connect What Matters is brought to life by more than 7,000 global team members who collaborate with customers across more than 30 market segments in over 140 countries to develop highly specified solutions that enable customers to bring world-changing innovations to their end markets. Learn more at www.hbfuller.com.

Safe Harbor for Forward-Looking Statements

Certain statements in this press release may be considered forward-looking statements within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements often address expected future business and financial performance, financial condition, and other matters, and often contain words or phrases such as “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “opportunity,” “outlook,” “plan,” “project,” “seek,” “should,” “strategy,” “target,” “will,” “will be,” “will continue,” “will likely result,” “would” and similar expressions, and variations or negatives of these words or phrases. These statements are subject to various risks and uncertainties that could cause our actual results to differ materially from those in the forward-looking statements, including but not limited to the following: the availability and pricing of raw materials; the impact of potential cybersecurity attacks and security breaches; the impact on the supply chain, raw material costs and pricing of our products due to military conflict, including between Russia and Ukraine and Israel and Hamas; the consequences of the COVID-19 outbreak and other pandemics on our operations and financial results; the impact on our margins and product demand due to inflationary pressures; the substantial amount of debt we have incurred to finance our acquisition of Royal, our ability to repay or refinance our debt or to incur additional debt in the future, our need for a significant amount of cash to service and repay the debt and to pay dividends on our common stock, and the effect of debt covenants that limit the discretion of management in operating the business or in paying dividends; our ability to pay dividends and to pursue growth opportunities if we continue to pay dividends according to our current dividend policy; our ability to acquire and integrate complementary businesses; our ability to achieve expected synergies, cost savings and operating efficiencies from our restructuring initiatives and operational improvement projects within the expected time frames or at all; our ability to effectively implement Project ONE; uncertain political and economic conditions; fluctuations in product demand; competing products and pricing; our geographic and product mix; disruptions to our relationships with our major customers and suppliers; failures in our information technology systems; regulatory compliance across our global footprint; trade policies and economic sanctions impacting our markets; changes in tax laws and tariffs; devaluations and other foreign exchange rate fluctuations; the impact of litigation and investigations, including for product liability and environmental matters; impairment charges on our goodwill or long-lived assets; the effect of new accounting pronouncements and accounting charges and credits; and similar matters.

Additional information about these various risks and uncertainties can be found in the “Risk Factors” section of our Form 10-K filings, and any updates to the risk factors in our Form 10-Q and 8-K filings with the SEC, but there may be other risks and uncertainties that we are unable to identify at this time or that we do not currently expect to have a material impact on the business. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. We do not undertake to update or revise any forward-looking statements, except as required by law.

H.B. FULLER COMPANY AND SUBSIDIARIES

REGULATION G RECONCILIATION

In thousands, except per share amounts (unaudited)

 

 

Year Ended
November 30,

 

 

2024

 

 

 

 

 

 

Net income attributable to H.B. Fuller

 

$

130,786

 

 

 

 

 

 

 

 

Adjustments:

 

 

 

 

 

Acquisition project costs 1

 

 

9,354

 

 

Organizational realignment 2

 

 

39,996

 

 

Project One 3

 

 

11,885

 

 

Business divestiture 4

 

 

48,948

 

 

Other 5

 

 

(1,981

)

 

Discrete tax items 6

 

 

(5,999

)

 

Income tax effect on adjustments 7

 

 

(15,811

)

 

Adjusted net income attributable to H.B. Fuller 8

 

 

217,178

 

 

 

 

 

 

 

 

Add:

 

 

 

 

 

Interest expense

 

 

133,122

 

 

Interest income

 

 

(4,679

)

 

Income taxes

 

 

77,661

 

 

Depreciation and Amortization expense 9

 

 

170,573

 

 

Adjusted EBITDA 8

 

 

593,855

 

 

 

 

 

 

 

 

Diluted Shares

 

 

56,629

 

 

Adjusted diluted income per common share attributable to H.B. Fuller 8

 

$

3.84

 

 

 

 

 

1 Acquisition project costs include costs related to evaluating, acquiring and integrating business acquisitions. Acquisition project costs include $8,037 in transaction costs (primarily consulting and professional fees, representations and warranties, insurance premiums and employee acquisition related travel expenses), $740 in purchase accounting costs (primarily professional fees for valuation services, inventory step-up cost and the impact of changes to contingent consideration liabilities after the completion of the purchase price allocation) and $577 in business integration costs (primarily costs of transition services agreements and, for the three month ended March 2, 2024, retention bonuses paid to employees of the acquired entities) for the year ended November 30, 2024.

2 Organizational realignment includes costs incurred as a direct result of the organizational realignment program, including professional fees related to legal entity and business structure changes, employee retention and severance costs, and facility rationalization costs related to the closure of production facilities and consolidation of business activities. Facility rationalization costs include plant closure costs, the impact of accelerated depreciation, and, for the three months ended March 2, 2024, operational inefficiencies. Organizational realignment includes $9,084 in professional fees related to legal entity and business structure changes, $16,553 in employee severance and other related costs and $14,359 related to facility rationalization costs for the year ended November 30, 2024.

3 Project One includes non-capitalizable project costs related to implementing our global Enterprise Resource Planning system, including upgrading to SAP S/4HANA®, which will upgrade and standardize our information system.

4 Business divestiture includes impairment losses for goodwill and long-lived assets, and project costs incurred as a direct result of the pending sale of the North America Flooring business, which is a component of our Construction Adhesives operating segment. Impairment losses represent the difference between the book value of the assets held for sale and their net realizable value.

5 Other includes a gain from insurance recoveries and a loss from the write-off of a cost method investment for the year ended November 30, 2024.

6 Discrete tax items for the year ended November 30, 2024 are related to various foreign tax matters as well as excess tax benefit related to U.S. stock compensation.

7 The income tax effect on adjustments represents the difference between income taxes on net income before income taxes and income from equity method investments reported in accordance with U.S. GAAP and adjusted net income before income taxes and income from equity method investments.

8 Adjusted net income attributable to H.B. Fuller, adjusted diluted income per common share attributable to H.B. Fuller and adjusted EBITDA are non-GAAP financial measures. Adjusted net income attributable to H.B. Fuller is defined as net income before the specific adjustments shown above. Adjusted diluted income per common share is defined as adjusted net income attributable to H.B. Fuller divided by the number of diluted common shares. Adjusted EBITDA is defined as net income before interest, income taxes, depreciation, amortization and the specific adjustments shown above. The table above provides a reconciliation of adjusted net income attributable to H.B. Fuller, adjusted diluted income per common share attributable to H.B. Fuller and adjusted EBITDA to net income attributable to H.B. Fuller, the most directly comparable financial measure determined and reported in accordance with U.S. GAAP.

9 Depreciation and amortization expense added back for EBITDA is adjusted for amounts already included in adjusted net income attributable to H.B. Fuller totaling ($4,137) for the year ended November 30, 2024.

 

Steven Brazones

Investor Relations Contact

651-236-5060

Source: H.B. Fuller Company

FAQ

What is H.B. Fuller's (FUL) revised EBITDA guidance for fiscal 2024?

H.B. Fuller has revised its fiscal 2024 adjusted EBITDA guidance to approximately $594 million, down from the previous guidance of $610-620 million.

What factors impacted H.B. Fuller's (FUL) Q4 2024 performance?

H.B. Fuller's Q4 performance was impacted by weaker market conditions, delayed orders in consumer goods and packaging markets, higher raw material costs, and delayed customer order patterns.

What is H.B. Fuller's (FUL) expected revenue for fiscal 2024?

H.B. Fuller expects fiscal year 2024 net revenue to be approximately $3.57 billion.

What actions is H.B. Fuller (FUL) taking to address the market challenges?

H.B. Fuller is implementing new pricing actions, cost controls, and continuing restructuring initiatives to streamline manufacturing and overall SG&A profile.

When will H.B. Fuller (FUL) release its full fiscal 2024 financial results?

H.B. Fuller will release its full fiscal 2024 financial results after market close on January 15, 2025, with an investor conference call scheduled for January 16, 2025.

H.B. Fuller Company

NYSE:FUL

FUL Rankings

FUL Latest News

FUL Stock Data

3.41B
54.43M
0.32%
98.73%
2.21%
Specialty Chemicals
Adhesives & Sealants
Link
United States of America
ST PAUL